tinidazole has been researched along with secnidazole in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 6 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Ang, CW; Blaskovich, MAT; Cooper, MA; Jarrad, AM | 1 |
| Hart, CJS; Riches, A; Skinner-Adams, TS; Trenholme, KR | 1 |
| Cho, YW; Maisonneuve, H; Rossignol, JF | 1 |
| Bhatia, SC; Shanbhag, VD | 1 |
| Decouvelaere, B; Pasquier, P; Populaire, P; Renard, A | 1 |
| Kanwar, AJ; Thami, GP | 1 |
| Brett, AM; Cruz, ML; Gutz, IG; La-Scalea, MA; Serrano, SH | 1 |
| Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S | 1 |
| Ortiz-Ibarra, J; Reyna-Figueroa, J; Villagrana-Zesati, R | 1 |
| Gu, Y; Li, X; Ren, H; Sun, J; Wang, G; Xie, H; Yan, B; Zheng, Y | 1 |
| Qian, XD; Wang, FM; Xu, H; Yu, HY | 1 |
| Alfonso, M; Almirall, P; Avila, I; Cimerman, S; Dawkins, IV; Escobedo, AA; Núñez, FA; Salazar, Y | 1 |
| Darwish, KM; El-Sadek, M; Mostafa, S; Salama, I | 1 |
| Deshpande, A; Escobedo, AA; Hernandez, AV; Pasupuleti, V; Roman, Y; Thota, P | 1 |
| Eckert, LO; Kus, LH; Neal, CM; Peipert, JF | 1 |
| Iza, JA; Iza, SN; Olivera, MJ | 1 |
| McNeil, CJ; Muzny, CA; Williamson, JC | 1 |
| Aguila, LKT; Cichewicz, RH; Kim, CM; Wood, GE | 1 |
| Kissinger, PJ; Muzny, CA | 1 |
| Boyd, P; Dallal Bashi, YH; Karl Malcolm, R; McCoy, CF; Zhao, X | 1 |
4 review(s) available for tinidazole and secnidazole
| Article | Year |
|---|---|
Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Communicable Diseases; Humans; Nitroimidazoles; Parasitic Diseases | 2017 |
Anti-
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Drug Delivery Systems; Drug Discovery; Drug Therapy, Combination; Gastrointestinal Tract; Giardia; Giardiasis; Humans; Nitroimidazoles | 2020 |
Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; Giardiasis; Humans; Infant; Infant, Newborn; Male; Metronidazole; Middle Aged; Randomized Controlled Trials as Topic; Tinidazole; Treatment Outcome; Young Adult | 2014 |
Noncandidal vaginitis: a comprehensive approach to diagnosis and management.
Topics: Administration, Intravaginal; Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; Atrophic Vaginitis; Candidiasis, Vulvovaginal; Clindamycin; Dehydroepiandrosterone; Diagnosis, Differential; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hydrocortisone; Inflammation; Lichen Planus; Metronidazole; Pemphigoid, Benign Mucous Membrane; Pemphigoid, Bullous; Pemphigus; Tamoxifen; Tinidazole; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial | 2020 |
3 trial(s) available for tinidazole and secnidazole
| Article | Year |
|---|---|
Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.
Topics: Adolescent; Adult; Azithromycin; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Pelvic Inflammatory Disease; Prospective Studies; Tinidazole | 2003 |
Short-term therapy for mixed vaginal infections.
Topics: Administration, Oral; Antifungal Agents; Antiprotozoal Agents; Antitrichomonal Agents; Candidiasis, Vulvovaginal; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Metronidazole; Patient Compliance; Tinidazole; Treatment Outcome; Trichomonas Vaginitis; Vaginosis, Bacterial | 2006 |
[Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis].
Topics: Administration, Intravaginal; Administration, Oral; Adult; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Metronidazole; Nitroimidazoles; Ornidazole; Prospective Studies; Tablets; Tinidazole; Treatment Outcome; Vaginosis, Bacterial; Young Adult | 2008 |
14 other study(ies) available for tinidazole and secnidazole
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis.
Topics: Amebiasis; Animals; Chemical Phenomena; Chemistry; Cricetinae; Female; Giardiasis; Humans; Metronidazole; Mice; Nitroimidazoles; Ornidazole; Rats; Structure-Activity Relationship; Tinidazole; Trichomonas Infections; Trichomonas Vaginitis | 1984 |
Electron-capture gas chromatographic assays of 5-nitroimidazole class of antimicrobials in blood.
Topics: Antitrichomonal Agents; Chromatography, Gas; Humans; Metronidazole; Nitroimidazoles; Ornidazole; Tinidazole | 1984 |
[Study of serum concentrations and urinary excretion of secnidazole after oral administration in man. Comparison with tinidazole].
Topics: Administration, Oral; Adult; Antitrichomonal Agents; Female; Humans; Kinetics; Male; Metronidazole; Tinidazole | 1980 |
Fixed drug eruption due to metronidazole and tinidazole without cross-sensitivity to secnidazole.
Topics: Adult; Antiprotozoal Agents; Cross Reactions; Drug Eruptions; Giardiasis; Humans; Male; Metronidazole; Tinidazole | 1998 |
Mechanism of interaction of in situ produced nitroimidazole reduction derivatives with DNA using electrochemical DNA biosensor.
Topics: Biosensing Techniques; DNA; DNA Damage; Electrodes; Metronidazole; Models, Chemical; Nitroimidazoles; Oxidation-Reduction; Tinidazole | 1999 |
Determination of secnidazole in human plasma by high-performance liquid chromatography with UV detection and its application to the bioequivalence studies.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Antiprotozoal Agents; Area Under Curve; Biological Availability; Calibration; Chromatography, High Pressure Liquid; Female; Humans; Male; Metronidazole; Plasma; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Therapeutic Equivalency; Tinidazole | 2007 |
Hospitalization of Cuban children for giardiasis: a retrospective study in a paediatric hospital in Havana.
Topics: Abdominal Pain; Antiprotozoal Agents; Child; Child, Preschool; Cuba; Diarrhea; Female; Giardiasis; Hospitalization; Hospitals, Pediatric; Humans; Infant; Length of Stay; Male; Medical Records; Metronidazole; Quinacrine; Retrospective Studies; Tinidazole; Treatment Outcome; Vomiting | 2011 |
Extractional spectrophotometric analysis of metronidazole, tinidazole, ornidazole and secnidazole bases through acid-dye complexation using bromothymol blue dye.
Topics: Acids; Bromthymol Blue; Chemistry, Pharmaceutical; Coloring Agents; Hydrogen-Ion Concentration; Injections; Metronidazole; Ornidazole; Solutions; Spectrophotometry, Ultraviolet; Tablets; Temperature; Time Factors; Tinidazole | 2012 |
Giardiasis: report of a case refractory to treatment.
Topics: Adult; Albendazole; Antiprotozoal Agents; Furazolidone; Giardia lamblia; Giardiasis; Humans; Male; Metronidazole; Nitro Compounds; Nitroimidazoles; Thiazoles; Tinidazole; Treatment Failure | 2019 |
Successful Treatment of Persistent 5-Nitroimidazole-Resistant Trichomoniasis With an Extended Course of Oral Secnidazole Plus Intravaginal Boric Acid.
Topics: Female; Humans; Metronidazole; Tinidazole; Trichomonas Infections; Trichomonas Vaginitis | 2023 |
Topics: Anti-Bacterial Agents; Doxycycline; Drug Resistance, Bacterial; Female; Humans; Male; Metronidazole; Mycoplasma genitalium; Mycoplasma Infections; Nitroimidazoles; Tinidazole | 2023 |
Where Do Tinidazole and Secnidazole Fit in With the Treatment of Trichomoniasis?
Topics: Female; Humans; Metronidazole; Nitroimidazoles; Tinidazole; Trichomonas Infections; Trichomonas Vaginitis | 2023 |
Physicochemical considerations in the formulation development of silicone elastomer vaginal rings releasing 5-nitroimidazole drugs for the treatment of bacterial vaginosis.
Topics: Administration, Intravaginal; Anti-Bacterial Agents; Contraceptive Devices, Female; Delayed-Action Preparations; Female; Humans; Metronidazole; Ornidazole; Silicone Elastomers; Tinidazole; Vaginosis, Bacterial | 2023 |